22 June 2018 - Martin Shkreli is in prison, but Daraprim still costs $750 per pill. Heather Bresch was hauled before Congress, but EpiPens still cost three to six times more than they did in 2007. 

Every week we hear of a new outrageous drug price increase. In polls, some 80 percent of Americans say that government should do more to curb drug prices.

Having proclaimed just before his inauguration that drug makers were “getting away with murder,” President Trump last month issued a 50-point blueprint to bring down prices, mainly by injecting more competition — and a dose of public shaming — into the market.

Though the document was light on specifics, containing more than 130 questions, it included proposals for speeding the development and sale of generics, strengthening insurers’ negotiating clout, and making pricing more transparent.

Read New York Times Opinion